Evaluation of Brain Natriuretic Peptide in the Diagnosis of Heart Failure
- 1 June 2000
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 93 (1-2) , 19-25
- https://doi.org/10.1159/000006997
Abstract
A diagnosis of heart failure (HF) can be difficult, especially in patients with mild symptomatology. The purpose of this study was to evaluate the significance of brain natriuretic peptide (BNP) in the diagnosis of HF with systolic or isolated diastolic ventricular dysfunction. One hundred patients and 9 controls were included in the study. Eighty-five patients were diagnosed with HF, based on clinical and echocardiographic findings. BNP levels were accurate for the diagnosis of HF, with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.92. In addition, BNP levels showed an excellent accuracy for the diagnosis of isolated diastolic HF (AUC = 0.89). These data suggest that the measurement of BNP levels may be helpful in the diagnosis of HF and in selecting patients for further evaluation. Furthermore, BNP measurement can play an important role in the diagnosis of isolated diastolic HF.This publication has 5 references indexed in Scilit:
- How to diagnose diastolic heart failureEuropean Heart Journal, 1998
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- The natriuretic-peptide familyThe Lancet, 1997
- Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease StudyThe Lancet, 1997
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsPublished by Elsevier ,1986